Health Care: Drugs

Imprimis Pharmaceuticals Inc (IMMY: NASDAQ)

$4.07 n/a | n/a%
07/22/16 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 4.07
52 Week High 8.79
52 Week Low 3.34
Avg. Daily Vol. (Mil) 0.03
Beta (3 year) -0.89
Share Related Items
Mkt Cap (Mil) 54.15
Shares Out (Mil) 13.31
Float (Mil) 11.91
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.30
Current Ratio 2.60
LT Debt/ Equity 1.04
Total Debt / Equity 1.04
Valuation Ratios
Price Earnings n.a.
Price/Sales 4.32
Price/Book 6.17
Price/Cash Flow -3.40
Per Share Data
Earnings -1.76
Sales 0.94
Book Value 0.66
Cash Flow -1.21
Business Summary
Imprimis Pharmaceuticals Inc is engaged in the development, production and dispensing of proprietary compounded pharmaceuticals. The Company is focused in ophthalmology, urology, and sinus drug therapies.
General Information
12264 EI Camino Real
Suite 350
San Diego, CA 92130
www.imprimispharma.com
Industry : Drugs
Sector: Health Care
Employees: 106
CEO: Mark L. Baum
Short Interest
Current Month (Mil) 0.16
Previous Month (Mil) 0.15
Short Interest Ratio (Days) 5.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -68.40
Return on Investments -96.80
Profitability
Gross Margin 58.10
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with IMMY

Latest IMMY Headlines from TheStreet

More Financial News for IMMY

Press Releases for IMMY

See All Press Releases

Partner Headlines for IMMY

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter